IMDEX LIMITED (IMD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IMD

IMD - IMDEX LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: 1.03
Index: ASX200 | ASX300 | ALL-ORDS

Imdex is an Australian mining tech company. It manufacturers & provides drilling fluids, chemicals, mining instumentation and data & geo-analytical services. Formed in 1980, it became a listed company in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.71

04 Apr
2025

-0.180

OPEN

$2.85

-6.23%

HIGH

$2.87

1,941,032

LOW

$2.65

TARGET
$2.93 8.1% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . C79 . CDA . DOW . EHL . GNG . IPG . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . RDG . RUL . SGH . SRG . SXE . XRF .
FNARENA'S MARKET CONSENSUS FORECASTS
IMD: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 6.4 9.5 xxx
DPS (cps) xxx 2.8 3.1 xxx
EPS Growth xxx - 20.0% 49.7% xxx
DPS Growth xxx - 22.2% 9.3% xxx
PE Ratio xxx N/A 28.5 xxx
Dividend Yield xxx N/A 1.1% xxx
Div Pay Ratio(%) xxx 44.0% 32.1% xxx

Dividend yield today if purchased 3 years ago: 1.05%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 1.03

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 25/09 - ex-div 1.30c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx6.4
DPS All xxxxxxxxxxxxxxx2.8
Sales/Revenue xxxxxxxxxxxxxxx445.3 M
Book Value Per Share xxxxxxxxxxxxxxx111.9
Net Operating Cash Flow xxxxxxxxxxxxxxx108.0 M
Net Profit Margin xxxxxxxxxxxxxxx7.28 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx5.75 %
Return on Invested Capital xxxxxxxxxxxxxxx4.80 %
Return on Assets xxxxxxxxxxxxxxx4.07 %
Return on Equity xxxxxxxxxxxxxxx5.75 %
Return on Total Capital xxxxxxxxxxxxxxx9.94 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx60.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx34 M
Long Term Debt xxxxxxxxxxxxxxx94 M
Total Debt xxxxxxxxxxxxxxx128 M
Goodwill - Gross xxxxxxxxxxxxxxx325 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx47 M
Price To Book Value xxxxxxxxxxxxxxx1.98

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx33.5 M
Capex % of Sales xxxxxxxxxxxxxxx7.53 %
Cost of Goods Sold xxxxxxxxxxxxxxx306 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx69 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx11 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

13/02/2025

3

Neutral

$2.95

8.86%

UBS raises its target for Imdex to $2.95 from $2.60 and maintains a Neutral rating following a further review of 1H results.

A summary of the broker's research penned yesterday follows.

UBS notes the 1H25 result from Imdex appears "fine" at first take, with the report sufficient to underpin the recent rally in the share price, the analyst states.

Revenue grew 1% on 2H24, while net profit after tax fell -19% on the previous corresponding period, meeting consensus expectations.

Management pointed to an increase in resource exploration budgets from Australian companies and expects better transparency in 3Q25 on other geographies, the broker notes. A positive outlook was flagged from FY26.

UBS highlights the consensus FY25 earnings forecast of $130m before interest, tax, and depreciation will require a 2H25 result of $66m, a rise of 11% year-on-year and 4% on 1H25.

FORECAST
UBS forecasts a full year FY25 dividend of 3.00 cents and EPS of 10.00 cents.
UBS forecasts a full year FY26 dividend of 3.00 cents and EPS of 12.00 cents.

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

17/02/2025

3

Downgrade to Neutral from Overweight

$2.45

-9.59%

Imdex reported 1H25 underlying EBITDA of $64m which was largely in line with consensus. Jarden is forecasting 2H25 EBITDA of $68m mainly due to forex benefits, as the company flagged flat activity into 2H.

The broker reckons further benefits from cost-out or operating leverage could emerge through 2H25, should activity return earlier than current management expectations of FY26.

The broker cut FY25 and FY26 EPS by -4% and -3% respectively. Target price rises to $2.45 from $2.30.

Rating downgraded to Neutral from Overweight until the broker sees evidence of stronger activity and earnings leverage in FY26. 

FORECAST
Jarden forecasts a full year FY25 dividend of 3.00 cents and EPS of 9.30 cents.
Jarden forecasts a full year FY26 dividend of 3.20 cents and EPS of 11.60 cents.
Access Extra Coverage Research History >

IMD STOCK CHART

FNArena News on IMD

1
Rudi’s View: Post February Conviction Calls

Mar 13 2025 - Rudi's View
2
In Case You Missed It – BC Extra Upgrades & Downgrades – 21-02-25

Feb 21 2025 - Weekly Reports
3
Australian Broker Call *Extra* Edition – Feb 18, 2025

Feb 18 2025 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Feb 17, 2025

Feb 17 2025 - Daily Market Reports
5
Weekly Ratings, Targets, Forecast Changes – 14-02-25

Feb 17 2025 - Weekly Reports

Latest Mining Sector Contracting News

1
Orica’s Transformation Proceeding Apace

Mar 24 2025 - Australia
2
NRW Holdings: Navigating The OneSteel Risk

Mar 05 2025 - Small Caps
3
Chrysos Corp’s Road Paved With Gold

Jan 24 2025 - Small Caps
4
Orica Shares Eyeing $21

Dec 10 2024 - Technicals
5
Renewed Uptrend For Monadelphous

Dec 03 2024 - Technicals
6
Orica Well Positioned To Capitalise

Nov 18 2024 - Australia
7
Risk Seems To The Upside For NRW Holdings

Aug 26 2024 - Small Caps
8
Monadelphous Shakes Off Lithium

Aug 22 2024 - Small Caps
9
Imdex’s Operational Leverage Attracts

Jun 06 2024 - Small Caps
10
Orica Resumes Up-Trend

Apr 16 2024 - Technicals